26
|
van der Noordaa ME, Esserman L, Yau C, Mukhtar R, Price E, Hylton N, Abe H, Wolverton D, Crane EP, Ward KA, Nelson M, Niell BL, Oh K, Brandt KR, Bang DH, Ojeda-Fournier H, Eghtedari M, Sheth PA, Bernreuter WK, Umphrey H, Rosen MA, Dogan B, Yang W, Joe B, van 't Veer L, Hirst G, Lancaster R, Wallace A, Alvaredo M, Symmans F, Asare S, Boughey JC. Abstract PD4-04: Role of breast MRI in predicting pathologically negative nodes after neoadjuvant chemotherapy in cN0 patients in the I-SPY2 trial. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd4-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
In clinically node-negative (cN0) breast cancer patients with triple negative (TN) and HER2+ disease and breast pathological complete response (breast pCR), low rates of nodal positivity after neoadjuvant chemotherapy (NAC) have been demonstrated. In these patients, the omission of surgical axillary staging has been proposed. However, this information is not routinely known preoperatively. We aimed to validate the correlation between pathologic breast response and pathologic nodal status, and evaluate the relationship between response of the breast tumor on MRI and pathologic nodal status after NAC in cN0 patients in the I-SPY2 trial.
Methods
We identified all patients with cT1-4 cN0 breast cancer prior to NAC from graduated arms of the I-SPY2 trial, a prospective neoadjuvant chemotherapy trial. Absence of residual disease post-NAC was defined as longest diameter (LD) of 0 mm on MRI. Breast pCR was defined as the absence of invasive tumor in the breast at surgery. Associations between ypN0 and patient, MRI, and tumor characteristics were assessed using chi-square tests and univariate regression.
Results
Of 365 cT1-4 cN0 patients included, 128 had HR+/HER2- tumors (35%), 60 HR+/HER2+ tumors (16%), 34 HR-/HER2+ tumors (9%) and 143 TN tumors (39%). Overall, 283 patients (78%) were ypN0 after NAC and 152 patients (42%) had a breast pCR. ypN0 rate was higher in patients with a breast pCR than those with residual disease (93% vs 66%, p<0.001). Patients with HR-/HER2+ and TN tumors were more likely to be ypN0 (97% and 87% respectively) than patients with HR+/HER2- and HR+/HER2+ disease (66% and 71% respectively, p<0.001). Other characteristics associated with ypN0 were tumor grade (grade I 57%, grade II 66%, grade III 84%; p=0.002), MammaPrint Classification (High Risk 1 68% and High Risk 2 87%; p<0.001) and absence of residual tumor in the breast on MRI (87% vs 72% in patients with evidence of tumor on MRI post-NAC/pre-surgery; p=0.003).
In patients with HR-/HER2+, HR+/HER2+, HR-/HER2+ or TN disease and a breast pCR, ypN0 rate was respectively 82%, 96%, 96% and 97% (table 1). In patients with HR+/HER2-, HR+/HER2+, HR-/HER2+ or TN disease and with no evidence of residual disease in the breast on MRI, rate of ypN0 was 71%, 80%, 94% and 96% respectively.
Conclusion
In cT1-4 cN0 breast cancer patients with HR+/HER2+, HR-/HER2+ and TN tumors and a breast pCR, ypN0 rates after NAC are extremely high. In patients with HR-/HER2+ and TN tumors with no residual breast disease on MRI after NAC and pre-surgery, ypN0 rates are high enough to consider omission of axillary surgery. In patients with HR+ tumors, MRI is unsufficiently predictive for pathological response and can therefore not be used to select ypN0 patients. Research on the prediction of ypN0 in cN+ I-SPY2 patients is ongoing.
Nodal status in patients with pCR and absence of residual disease on MRI Number of positive nodesBreast Cancer Subtype0123AllBreast pCR HR+/HER2-27(82)2(6)4(12)033(100)HR+/HER2+24(96)01(4)025(100)HR-/HER2+24(96)1(4)0025(100)TN67(97)2(3)0069(100)Absence of residual disease on MRI HR+/HER2-24(71)7(21)3(9)034(100)HR+/HER2+16(80)3(15)01(5)20(100)HR-/HER2+15(94)1(6)0016(100)TN54(96)2(4)0056(100)
Citation Format: van der Noordaa ME, Esserman L, Yau C, Mukhtar R, Price E, Hylton N, Abe H, Wolverton D, Crane EP, Ward KA, Nelson M, Niell BL, Oh K, Brandt KR, Bang DH, Ojeda-Fournier H, Eghtedari M, Sheth PA, Bernreuter WK, Umphrey H, Rosen MA, Dogan B, Yang W, Joe B, van 't Veer L, Hirst G, Lancaster R, Wallace A, Alvaredo M, Symmans F, Asare S, Boughey JC, I-SPY2 Consortium. Role of breast MRI in predicting pathologically negative nodes after neoadjuvant chemotherapy in cN0 patients in the I-SPY2 trial [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD4-04.
Collapse
|
27
|
Hylton NM, Symmans WF, Yau C, Li W, Hatzis C, Isaacs C, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal I, Tawfik O, Grasso LeBeau L, Sahoo S, Vinh T, Yang S, Adams A, Chien AJ, Ferero-Torres A, Stringer-Reasor E, Wallace A, Boughey JC, Ellis ED, Elias AD, Lang JE, Lu J, Han HS, Clark AS, Korde L, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Wood WC, Park JW, Liu MC, Olopade O, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen PK, van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Sanil A, Berry SM, Abe H, Wolverton D, Crane EP, Ward KA, Nelson M, Niell BL, Oh K, Brandt KR, Bang DH, Ojeda-Fournier H, Eghtedari M, Sheth PA, Bernreuter WK, Umphrey H, Rosen MA, Dogan B, Yang W, Joe B, Yee D, Pusztai L, DeMichele A, Asare SM, Berry DA, Esserman LJ. Abstract P2-07-03: Refining neoadjuvant predictors of three year distant metastasis free survival: Integrating volume change as measured by MRI with residual cancer burden. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-07-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Patients achieving a pathologic complete response (pCR) following neoadjuvant therapy have significantly improved event-free survival relative to those who do not; and pCR is an FDA-accepted endpoint to support accelerated approval of novel agents/combinations in the neoadjuvant treatment of high risk early stage breast cancer. Previous studies have shown that recurrence risk increased with increasing burden of residual disease (as assessed by the RCB index). As well, these studies suggest that patients with minimum residual disease (RCB-I class) also have favorable outcomes (comparable to those achieving a pCR) within high risk tumor subtypes. In this study, we assess whether integrating RCB with MRI functional tumor volume (FTV), which in itself is prognostic, can improve prediction of distant recurrence free survival (DRFS); and identify a subset of patients with minimal residual disease with comparable DRFS as those who achieved a pCR. Imaging tools can then be used to identify the subset that will do well early and guide the timing of surgical therapy.
Method: We performed a pooled analysis of 596 patients from the I-SPY2 TRIAL with RCB, pre-surgical MRI FTV data and known follow-up (median 2.5 years). We first assessed whether FTV predicts residual disease (pCR or pCR/RCB-I) using ROC analysis. We applied a power transformation to normalize the pre-surgical FTV distribution; and assessed its association with DRFS using a bi-variate Cox proportional hazard model adjusting for HR/HER2 subtype. We also fitted a bivariate Cox model of RCB index adjusting for subtype; and assessed whether adding pre-surgical FTV to this model further improves association with DRFS using a likelihood ratio (LR) test. For the Cox modeling, penalized splines approximation of the transformed FTV and RCB index with 2 degrees of freedom was used to allow for non-linear effects of FTV and RCB on DRFS.
Result: Pre-surgical MRI FTV is significantly associated with DRFS (Wald p<0.00001), and more effective at predicting pCR/RCB-I than predicting pCR alone (AUC: 0.72 vs. 0.65). Larger pre-surgical FTV remains associated with worse DRFS adjusting for subtype (Wald p <0.00001). The RCB index is also significantly associated with DRFS adjusting for subtype (Wald p<0.00001). Adding FTV to a model containing RCB and subtype further improves association with DRFS (LR p=0.0007). RCB-I patients have excellent DRFS (94% at 3 years compared to 95% in the pCR group). Efforts are underway to identify an optimal threshold for dichotomizing pre-surgical FTV and FTV change measures for use in combination with pCR/RCB-I class to generate integrated RCB (iRCB) groups as a composite predictor of DRFS.
Conclusion: Pre-surgical MRI FTV is effective at predicting minimal residual disease (RCB0/I) in the I-SPY 2 TRIAL. Despite the association between FTV and RCB, FTV appears to provide independent added prognostic value (to RCB and subtype), suggesting that integrating MRI volume measures and RCB into a composite predictor may improve DRFS prediction.
Citation Format: Hylton NM, Symmans WF, Yau C, Li W, Hatzis C, Isaacs C, Albain KS, Chen Y-Y, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal I, Tawfik O, Grasso LeBeau L, Sahoo S, Vinh T, Yang S, Adams A, Chien AJ, Ferero-Torres A, Stringer-Reasor E, Wallace A, Boughey JC, Ellis ED, Elias AD, Lang JE, Lu J, Han HS, Clark AS, Korde L, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Wood WC, Park JW, Liu MC, Olopade O, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen PK, van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Sanil A, Berry SM, Abe H, Wolverton D, Crane EP, Ward KA, Nelson M, Niell BL, Oh K, Brandt KR, Bang DH, Ojeda-Fournier H, Eghtedari M, Sheth PA, Bernreuter WK, Umphrey H, Rosen MA, Dogan B, Yang W, Joe B, I-SPY 2 TRIAL Consortium, Yee D, Pusztai L, DeMichele A, Asare SM, Berry DA, Esserman LJ. Refining neoadjuvant predictors of three year distant metastasis free survival: Integrating volume change as measured by MRI with residual cancer burden [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-07-03.
Collapse
|
28
|
Schwab R, Clark A, Yau C, Wolf D, Chien AJ, Majure M, Ewing C, Wallace A, Roesch E, Helsten T, Forero A, Stringer-Reasor E, Vaklavas C, Nanda R, Jaskowiak N, Boughey J, Haddad T, Han H, Lee C, Albain K, Isaacs C, Elias A, Ellis E, Shah P, Lang J, Lu J, Tripathy D, Kemmer K, Yee D, Haley B, Korde L, Edmiston K, Northfelt D, Viscusi R, Khan Q, Symmans WF, Perlmutter J, Hylton N, Rugo H, Melisko M, Wilson A, Singhrao R, Asare S, van't Veer L, DeMichele A, Berry D, Esserman L. Abstract P1-15-02: Withdrawn. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-15-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Citation Format: Schwab R, Clark A, Yau C, Wolf D, Chien AJ, Majure M, Ewing C, Wallace A, Roesch E, Helsten T, Forero A, Stringer-Reasor E, Vaklavas C, Nanda R, Jaskowiak N, Boughey J, Haddad T, Han H, Lee C, Albain K, Isaacs C, Elias A, Ellis E, Shah P, Lang J, Lu J, Tripathy D, Kemmer K, Yee D, Haley B, Korde L, Edmiston K, Northfelt D, Viscusi R, Khan Q, I-SPY 2 Consortium, Symmans WF, Perlmutter J, Hylton N, Rugo H, Melisko M, Wilson A, Singhrao R, Asare S, van't Veer L, DeMichele A, Berry D, Esserman L. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-15-02.
Collapse
|
29
|
Aartsen M, Ackermann M, Adams J, Aguilar J, Ahlers M, Ahrens M, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Backes P, Bagherpour H, Bai X, Barbano A, Barron J, Barwick S, Baum V, Bay R, Beatty J, Becker KH, Becker Tjus J, BenZvi S, Berley D, Bernardini E, Besson D, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Böser S, Botner O, Bourbeau E, Bourbeau J, Bradascio F, Braun J, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Busse R, Carver T, Chen C, Cheung E, Chirkin D, Clark K, Classen L, Collin G, Conrad J, Coppin P, Correa P, Cowen D, Cross R, Dave P, de André J, De Clercq C, DeLaunay J, Dembinski H, Deoskar K, De Ridder S, Desiati P, de Vries K, de Wasseige G, de With M, DeYoung T, Díaz-Vélez J, Dujmovic H, Dunkman M, Dvorak E, Eberhardt B, Ehrhardt T, Eller P, Evenson P, Fahey S, Fazely A, Felde J, Filimonov K, Finley C, Franckowiak A, Friedman E, Fritz A, Gaisser T, Gallagher J, Ganster E, Garrappa S, Gerhardt L, Ghorbani K, Giang W, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez J, Grant D, Griffith Z, Gündüz M, Haack C, Hallgren A, Halve L, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Henningsen F, Hickford S, Hignight J, Hill G, Hoffman K, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Hünnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jacobi E, Japaridze G, Jeong M, Jero K, Jones B, Kalaczynski P, Kang W, Kappes A, Kappesser D, Karg T, Karl M, Karle A, Katz U, Kauer M, Keivani A, Kelley J, Kheirandish A, Kim J, Kintscher T, Kiryluk J, Kittler T, Klein S, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen D, Kowalski M, Krings K, Krückl G, Kunwar S, Kurahashi N, Kyriacou A, Labare M, Lanfranchi J, Larson M, Lauber F, Lazar J, Leonard K, Leuermann M, Liu Q, Lohfink E, Lozano Mariscal C, Lu L, Lünemann J, Luszczak W, Madsen J, Maggi G, Mahn K, Makino Y, Mallot K, Mancina S, Mariş I, Maruyama R, Mase K, Maunu R, Meagher K, Medici M, Medina A, Meier M, Meighen-Berger S, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moore R, Moulai M, Nagai R, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki S, Nygren D, Obertacke Pollmann A, Olivas A, O’Murchadha A, O’Sullivan E, Palczewski T, Pandya H, Pankova D, Park N, Peiffer P, Pérez de los Heros C, Pieloth D, Pinat E, Pizzuto A, Plum M, Price P, Przybylski G, Raab C, Raissi A, Rameez M, Rauch L, Rawlins K, Rea I, Reimann R, Relethford B, Renzi G, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Safa I, Sanchez Herrera S, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka K, Schaufel M, Schlunder P, Schmidt T, Schneider A, Schneider J, Schumacher L, Sclafani S, Seckel D, Seunarine S, Silva M, Snihur R, Soedingrekso J, Soldin D, Song M, Spiczak G, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stein R, Stettner J, Steuer A, Stezelberger T, Stokstad R, Stößl A, Strotjohann N, Stuttard T, Sullivan G, Sutherland M, Taboada I, Tenholt F, Ter-Antonyan S, Terliuk A, Tilav S, Tomankova L, Tönnis C, Toscano S, Tosi D, Tselengidou M, Tung C, Turcati A, Turcotte R, Turley C, Ty B, Unger E, Unland Elorrieta M, Usner M, Vandenbroucke J, Van Driessche W, van Eijk D, van Eijndhoven N, Vanheule S, van Santen J, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Wandler F, Watson T, Weaver C, Weiss M, Weldert J, Wendt C, Werthebach J, Westerhoff S, Whelan B, Whitehorn N, Wiebe K, Wiebusch C, Wille L, Williams D, Wills L, Wolf M, Wood J, Wood T, Woolsey E, Woschnagg K, Wrede G, Xu D, Xu X, Xu Y, Yanez J, Yodh G, Yoshida S, Yuan T. Measurement of atmospheric tau neutrino appearance with IceCube DeepCore. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.99.032007] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
30
|
Aartsen M, Ackermann M, Adams J, Aguilar J, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Backes P, Bagherpour H, Bai X, Barbano A, Barron J, Barwick S, Baum V, Bay R, Beatty J, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson D, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Böser S, Botner O, Bourbeau E, Bourbeau J, Bradascio F, Braun J, Brenzke M, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Busse R, Carver T, Cheung E, Chirkin D, Clark K, Classen L, Collin G, Conrad J, Coppin P, Correa P, Cowen D, Cross R, Dave P, Day M, de André J, De Clercq C, DeLaunay J, Dembinski H, Deoskar K, De Ridder S, Desiati P, de Vries K, de Wasseige G, de With M, DeYoung T, Díaz-Vélez J, di Lorenzo V, Dujmovic H, Dumm J, Dunkman M, Dvorak E, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Evenson P, Fahey S, Fazely A, Felde J, Filimonov K, Finley C, Franckowiak A, Friedman E, Fritz A, Gaisser T, Gallagher J, Ganster E, Garrappa S, Gerhardt L, Ghorbani K, Giang W, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez J, Grant D, Griffith Z, Haack C, Hallgren A, Halve L, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill G, Hoffman K, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Hünnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jacobi E, Japaridze G, Jeong M, Jero K, Jones B, Kalaczynski P, Kang W, Kappes A, Kappesser D, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley J, Kheirandish A, Kim J, Kintscher T, Kiryluk J, Kittler T, Klein S, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koschinsky J, Koskinen D, Kowalski M, Krings K, Kroll M, Krückl G, Kunwar S, Kurahashi N, Kyriacou A, Labare M, Lanfranchi J, Larson M, Lauber F, Leonard K, Leuermann M, Liu Q, Lohfink E, Lozano Mariscal C, Lu L, Lünemann J, Luszczak W, Madsen J, Maggi G, Mahn K, Makino Y, Mancina S, Mariş I, Maruyama R, Mase K, Maunu R, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moore R, Moulai M, Nagai R, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki S, Nygren D, Obertacke Pollmann A, Olivas A, O’Murchadha A, O’Sullivan E, Palczewski T, Pandya H, Pankova D, Peiffer P, Pepper J, Pérez de los Heros C, Pieloth D, Pinat E, Pizzuto A, Plum M, Price P, Przybylski G, Raab C, Rameez M, Rauch L, Rawlins K, Rea I, Reimann R, Relethford B, Renzi G, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Safa I, Sanchez Herrera S, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka K, Schaufel M, Schlunder P, Schmidt T, Schneider A, Schneider J, Schöneberg S, Schumacher L, Sclafani S, Seckel D, Seunarine S, Soedingrekso J, Soldin D, Song M, Spiczak G, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stein R, Stettner J, Steuer A, Stezelberger T, Stokstad R, Stößl A, Strotjohann N, Stuttard T, Sullivan G, Sutherland M, Taboada I, Tenholt F, Ter-Antonyan S, Terliuk A, Tilav S, Toale P, Tobin M, Tönnis C, Toscano S, Tosi D, Tselengidou M, Tung C, Turcati A, Turley C, Ty B, Unger E, Unland Elorrieta M, Usner M, Vandenbroucke J, Van Driessche W, van Eijk D, van Eijndhoven N, Vanheule S, van Santen J, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandler F, Wandkowsky N, Watson T, Waza A, Weaver C, Weiss M, Wendt C, Werthebach J, Westerhoff S, Whelan B, Whitehorn N, Wiebe K, Wiebusch C, Wille L, Williams D, Wills L, Wolf M, Wood J, Wood T, Woolsey E, Woschnagg K, Wrede G, Xu D, Xu X, Xu Y, Yanez J, Yodh G, Yoshida S, Yuan T. Measurements using the inelasticity distribution of multi-TeV neutrino interactions in IceCube. Int J Clin Exp Med 2019. [DOI: 10.1103/physrevd.99.032004] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
31
|
Wallace A, Marcuzzi D, Ko M, Latter D. Anterior mediastinal mass 4 years after type A aortic dissection. J Surg Case Rep 2019; 2019:rjz010. [PMID: 30740207 PMCID: PMC6354677 DOI: 10.1093/jscr/rjz010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2018] [Revised: 01/02/2019] [Accepted: 01/11/2019] [Indexed: 11/29/2022] Open
Abstract
A 47-year-old male who previously underwent emergency surgery for type A aortic dissection presented to the emergency department 4 years later with acute chest pain radiating to his back and a significant drop in hemoglobin. Clinical presentation was concerning for aortic graft failure, but imaging revealed a large (6.0 × 3.2 × 12.8 cm3) soft tissue mediastinal mass that was not present 4 years before. Pathologic analysis revealed a rare thymic cyst with a hemorrhagic component. This was a challenging case from diagnostic and operative perspectives, involving the expertise of both cardiac and thoracic surgical teams.
Collapse
|
32
|
Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Backes P, Bagherpour H, Bai X, Barbano A, Barron JP, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Böser S, Botner O, Bourbeau E, Bourbeau J, Bradascio F, Braun J, Brenzke M, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Busse RS, Carver T, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Collin GH, Conrad JM, Coppin P, Correa P, Cowen DF, Cross R, Dave P, Day M, de André JPAM, De Clercq C, DeLaunay JJ, Dembinski H, Deoskar K, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Dvorak E, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Evans PA, Evenson PA, Fahey S, Fazely AR, Felde J, Filimonov K, Finley C, Franckowiak A, Friedman E, Fritz A, Gaisser TK, Gallagher J, Ganster E, Gerhardt L, Ghorbani K, Giang W, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Griffith Z, Haack C, Hallgren A, Halve L, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Hünnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Kalaczynski P, Kang W, Kappes A, Kappesser D, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kheirandish A, Kim J, Kintscher T, Kiryluk J, Kittler T, Klein SR, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koschinsky JP, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Kunwar S, Kurahashi N, Kyriacou A, Labare M, Lanfranchi JL, Larson MJ, Lauber F, Leonard K, Leuermann M, Liu QR, Lohfink E, Lozano Mariscal CJ, Lu L, Lünemann J, Luszczak W, Madsen J, Maggi G, Mahn KBM, Makino Y, Mancina S, Mariş IC, Maruyama R, Mase K, Maunu R, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moore RW, Moulai M, Nagai R, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, O'Murchadha A, Osborne JP, O'Sullivan E, Palczewski T, Pandya H, Pankova DV, Peiffer P, Pepper JA, Pérez de Los Heros C, Pieloth D, Pinat E, Pizzuto A, Plum M, Price PB, Przybylski GT, Raab C, Rameez M, Rauch L, Rawlins K, Rea IC, Reimann R, Relethford B, Renzi G, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Safa I, Sanchez Herrera SE, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka K, Schaufel M, Schlunder P, Schmidt T, Schneider A, Schneider J, Schöneberg S, Schumacher L, Sclafani S, Seckel D, Seunarine S, Soedingrekso J, Soldin D, Song M, Spiczak GM, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stein R, Stettner J, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Strotjohann NL, Stuttard T, Sullivan GW, Sutherland M, Taboada I, Tenholt F, Ter-Antonyan S, Terliuk A, Tilav S, Toale PA, Tobin MN, Tönnis C, Toscano S, Tosi D, Tselengidou M, Tung CF, Turcati A, Turley CF, Ty B, Unger E, Unland Elorrieta MA, Usner M, Vandenbroucke J, Van Driessche W, van Eijk D, van Eijndhoven N, Vanheule S, van Santen J, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandler FD, Wandkowsky N, Watson TB, Waza A, Weaver C, Weiss MJ, Wendt C, Werthebach J, Westerhoff S, Whelan BJ, Whitehorn N, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wills L, Wolf M, Wood J, Wood TR, Woolsey E, Woschnagg K, Wrede G, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Yuan T. Constraints on Minute-Scale Transient Astrophysical Neutrino Sources. PHYSICAL REVIEW LETTERS 2019; 122:051102. [PMID: 30822017 DOI: 10.1103/physrevlett.122.051102] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2018] [Revised: 11/12/2018] [Indexed: 06/09/2023]
Abstract
High-energy neutrino emission has been predicted for several short-lived astrophysical transients including gamma-ray bursts (GRBs), core-collapse supernovae with choked jets, and neutron star mergers. IceCube's optical and x-ray follow-up program searches for such transient sources by looking for two or more muon neutrino candidates in directional coincidence and arriving within 100 s. The measured rate of neutrino alerts is consistent with the expected rate of chance coincidences of atmospheric background events and no likely electromagnetic counterparts have been identified in Swift follow-up observations. Here, we calculate generic bounds on the neutrino flux of short-lived transient sources. Assuming an E^{-2.5} neutrino spectrum, we find that the neutrino flux of rare sources, like long gamma-ray bursts, is constrained to <5% of the detected astrophysical flux and the energy released in neutrinos (100 GeV to 10 PeV) by a median bright GRB-like source is <10^{52.5} erg. For a harder E^{-2.13} neutrino spectrum up to 30% of the flux could be produced by GRBs and the allowed median source energy is <10^{52} erg. A hypothetical population of transient sources has to be more common than 10^{-5} Mpc^{-3} yr^{-1} (5×10^{-8} Mpc^{-3} yr^{-1} for the E^{-2.13} spectrum) to account for the complete astrophysical neutrino flux.
Collapse
|
33
|
Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Samarai IA, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Backes P, Bagherpour H, Bai X, Barron JP, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Böser S, Botner O, Bourbeau E, Bourbeau J, Bradascio F, Braun J, Brenzke M, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Busse RS, Carver T, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Collin GH, Conrad JM, Coppin P, Correa P, Cowen DF, Cross R, Dave P, Day M, de André JPAM, De Clercq C, DeLaunay JJ, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Dvorak E, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Evenson PA, Fahey S, Fazely AR, Felde J, Filimonov K, Finley C, Flis S, Franckowiak A, Friedman E, Fritz A, Gaisser TK, Gallagher J, Ganster E, Gerhardt L, Ghorbani K, Giang W, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Griffith Z, Haack C, Hallgren A, Halve L, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Hünnefeld M, Hussain R, In S, Iovine N, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Kalaczynski P, Kang W, Kappes A, Kappesser D, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kheirandish A, Kim J, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein SR, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koschinsky JP, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Kunwar S, Kurahashi N, Kuwabara T, Kyriacou A, Labare M, Lanfranchi JL, Larson MJ, Lauber F, Leonard K, Lesiak-Bzdak M, Leuermann M, Liu QR, Lohfink E, Mariscal CJL, Lu L, Lünemann J, Luszczak W, Madsen J, Maggi G, Mahn KBM, Mancina S, Maruyama R, Mase K, Maunu R, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moore RW, Moulai M, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, O’Murchadha A, O’Sullivan E, Palczewski T, Pandya H, Pankova DV, Peiffer P, Pepper JA, Pérez de los Heros C, Pieloth D, Pinat E, Plum M, Price PB, Przybylski GT, Raab C, Rädel L, Rameez M, Rauch L, Rawlins K, Rea IC, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Safa I, Sanchez Herrera SE, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka K, Schaufel M, Schlunder P, Schmidt T, Schneider A, Schoenen S, Schöneberg S, Schumacher L, Sclafani S, Seckel D, Seunarine S, Soedingrekso J, Soldin D, Song M, Spiczak GM, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stein R, Stettner J, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Strotjohann NL, Stuttard T, Sullivan GW, Sutherland M, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tilav S, Toale PA, Tobin MN, Tönnis C, Toscano S, Tosi D, Tselengidou M, Tung CF, Turcati A, Turley CF, Ty B, Unger E, Usner M, Vandenbroucke J, Van Driessche W, van Eijk D, van Eijndhoven N, Vanheule S, van Santen J, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandler FD, Wandkowsky N, Waza A, Weaver C, Weiss MJ, Wendt C, Werthebach J, Westerhoff S, Whelan BJ, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wills L, Wolf M, Wood J, Wood TR, Woolsey E, Woschnagg K, Wrede G, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Yuan T. Search for neutrinos from decaying dark matter with IceCube: IceCube Collaboration. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2018; 78:831. [PMID: 30930683 PMCID: PMC6405043 DOI: 10.1140/epjc/s10052-018-6273-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/10/2018] [Accepted: 09/21/2018] [Indexed: 06/09/2023]
Abstract
With the observation of high-energy astrophysical neutrinos by the IceCube Neutrino Observatory, interest has risen in models of PeV-mass decaying dark matter particles to explain the observed flux. We present two dedicated experimental analyses to test this hypothesis. One analysis uses 6 years of IceCube data focusing on muon neutrino 'track' events from the Northern Hemisphere, while the second analysis uses 2 years of 'cascade' events from the full sky. Known background components and the hypothetical flux from unstable dark matter are fitted to the experimental data. Since no significant excess is observed in either analysis, lower limits on the lifetime of dark matter particles are derived: we obtain the strongest constraint to date, excluding lifetimes shorter than10 28 s at 90% CL for dark matter masses above 10 TeV .
Collapse
|
34
|
Rack S, Brady G, Wallace A, Galvin M, Frese K, Krebs M, Dive C, Rothwell D, Ayub M, Cook N. Molecular profiling of tumour and ctDNA in a gastrointestinal cancer cohort at an academic cancer centre. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy314.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Wallace A, Lambert E, Sheridan B, Hunter I. Supracondylar fractures with a pink hand: Beware the tear! Int J Surg 2018. [DOI: 10.1016/j.ijsu.2018.05.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
36
|
Altman A, Wallace A, Jiang T, Okafor E, Lionberg A, Oladini F, Baron A, Matsumoto M, Sharma M, Patel P, Funaki B, Chang P. 3:54 PM Abstract No. 147 Prebiopsy labs for patients without conditions predisposing to coagulopathy: are they really necessary? J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
37
|
Chang R, Hillen T, Wallace A, Tomasian A, Jennings J. Abstract No. 491 Simultaneous bipedicular radiofrequency ablation for local tumor control of vertebral metastases. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
38
|
Shuford RA, Dulaney CR, Wallace A. Abstract P5-22-13: Representation of surgical breast research at an interdisciplinary oncology conference. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-22-13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The treatment of breast cancer requires an interdisciplinary approach, involving the fields of surgery, radiation oncology, medical oncology, pathology and radiology. The roles of various specialties may differ in the local versus metastatic setting. Despite the importance of collaborative care, significant disparities remain in federal funding of research among different medical specialties. The purpose of this analysis is to evaluate the representation of the surgical specialty at an interdisciplinary oncology research conference.
Methods: All electronically available abstracts in the breast cancer local, regional, adjuvant or breast cancer metastatic categories at American Society of Clinical Oncology (ASCO) 2017 annual meeting were reviewed. All abstracts containing the word “breast” in the title of other relevant categories were also included. These categories included developmental therapeutics, patient and survivor care, brain metastases, cancer prevention/hereditary genetics/epidemiology, tumor biology, health services/clinical informatics/quality of care. Only abstracts in these categories that were presented via poster or oral presentation at the annual meeting were included. The medical discipline, gender, and country of institution were recorded for each first and last author. Country of institution was recorded based on abstract reported affiliation. Gender and medical discipline were recorded based on information from academic and industry profiles available online.
Results: A total of 301 breast cancer posters (n = 276) and oral abstracts (n = 25) were presented at ASCO 2017. The majority of first (56.8%) and last (56.1%) authorships were from institutions in the United States. Geographic distribution of surgical first authors was as follows: 50.0% United States, 13.9% Europe and 36.1% Asia. While medical oncology represented the majority of first (59.5%) and final authorships (61.8%), surgery was underrepresented at 12.0% of first and 9.0% of final authors. When only non-metastatic breast cancer related abstracts were included (n = 142) surgical representation improved for both first (18.3%) and final (14.1%) authorship. While low in comparison to medical oncology, representation for the field of surgery was better than that of radiation oncology (2.3% first and 2.0% last authors), pathology (2.7% first and 3.3% last authors), and radiology (1.7% both first and last authors). In the entire cohort, female researchers were well represented as first authors (50.8%), but less often as final authors (41.9%). Representation of female surgeons was variable based on authorship: 61.1% of surgical first authors were female, but only 37% of surgical final authors were women.
Conclusions: The treatment of breast cancer requires a multidisciplinary approach. However, despite the collaborative nature of care, researchers in the field of surgery were less likely to present scholarly activity at ASCO 2017. This is likely multifactorial, and warrants further research to identify barriers and facilitators of surgical participation in the conduct and reporting of breast cancer surgical research.
Citation Format: Shuford RA, Dulaney CR, Wallace A. Representation of surgical breast research at an interdisciplinary oncology conference [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-22-13.
Collapse
|
39
|
Khan M, Halkyard E, Wallace A, Burghel G, Zhou C, Blackhall F. Does EGFR genome analysis turnaround time affect the length of survival of patients with EGFR positive non-small cell lung cancer? Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30051-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Tay R, Carter M, Wallace A, Burghel G, Halkyard E, Khan M, Blackhall F. Use of plasma circulating tumour DNA to detect epidermal growth factor receptor (EGFR) mutations: results from a ctDNA service in the north-west of England. Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30071-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Quinn A, Basnet M, McNulty C, Mayers H, Ganjifrockwala A, Cotterill A, Wallace A, Blackhall F, Sutton P. Establishing ALK immunohisto/cytochemistry testing in multiple centres within Greater Manchester; lessons learned, benefits and consequences. Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30083-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
42
|
Nadira N, Al-Najjar H, Higgins C, Wallace A, Harris J, Bailey S, Shelton D, Thiryayi S, Rana D. P1.03-001 Verification and Implementation of the VENTANA Anti-ALK D5F3 Antibody in Detecting ALK Rearrangement in NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Aartsen MG, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Archinger M, Argüelles C, Auffenberg J, Axani S, Bagherpour H, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Bradascio F, Braun J, Brayeur L, Bretz HP, Bron S, Burgman A, Carver T, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin GH, Conrad JM, Cowen DF, Cross R, Day M, de André JPAM, De Clercq C, del Pino Rosendo E, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Euler S, Evenson PA, Fahey S, Fazely AR, Feintzeig J, Felde J, Filimonov K, Finley C, Flis S, Fösig CC, Franckowiak A, Friedman E, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Gladstone L, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez JG, Grant D, Griffith Z, Haack C, Hallgren A, Halzen F, Hansen E, Hansmann T, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Hoshina K, Huang F, Huber M, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Kang W, Kappes A, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kheirandish A, Kim J, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein SR, Kohnen G, Koirala R, Kolanoski H, Konietz R, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Krüger C, Kunnen J, Kunwar S, Kurahashi N, Kuwabara T, Kyriacou A, Labare M, Lanfranchi JL, Larson MJ, Lauber F, Lennarz D, Lesiak-Bzdak M, Leuermann M, Lu L, Lünemann J, Madsen J, Maggi G, Mahn KBM, Mancina S, Maruyama R, Mase K, Maunu R, McNally F, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moulai M, Nahnhauer R, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, O’Murchadha A, Palczewski T, Pandya H, Pankova DV, Peiffer P, Penek Ö, Pepper JA, Pérez de los Heros C, Pieloth D, Pinat E, Price PB, Przybylski GT, Quinnan M, Raab C, Rädel L, Rameez M, Rawlins K, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Sabbatini L, Sanchez Herrera SE, Sandrock A, Sandroos J, Sarkar S, Satalecka K, Schlunder P, Schmidt T, Schoenen S, Schöneberg S, Schumacher L, Seckel D, Seunarine S, Soldin D, Song M, Spiczak GM, Spiering C, Stachurska J, Stanev T, Stasik A, Stettner J, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Toscano S, Tosi D, Tselengidou M, Tung CF, Turcati A, Unger E, Usner M, Vandenbroucke J, van Eijndhoven N, Vanheule S, van Rossem M, van Santen J, Vehring M, Voge M, Vogel E, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Waza A, Weaver C, Weiss MJ, Wendt C, Westerhoff S, Whelan BJ, Wickmann S, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wills L, Wolf M, Wood TR, Woolsey E, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zoll M. Measurement of the ν μ energy spectrum with IceCube-79: IceCube Collaboration. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2017; 77:692. [PMID: 31997925 PMCID: PMC6956919 DOI: 10.1140/epjc/s10052-017-5261-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2017] [Accepted: 09/25/2017] [Indexed: 06/09/2023]
Abstract
IceCube is a neutrino observatory deployed in the glacial ice at the geographic South Pole. The ν μ energy unfolding described in this paper is based on data taken with IceCube in its 79-string configuration. A sample of muon neutrino charged-current interactions with a purity of 99.5% was selected by means of a multivariate classification process based on machine learning. The subsequent unfolding was performed using the software Truee. The resulting spectrum covers an E ν -range of more than four orders of magnitude from 125 GeV to 3.2 PeV. Compared to the Honda atmospheric neutrino flux model, the energy spectrum shows an excess of more than 1.9 σ in four adjacent bins for neutrino energies E ν ≥ 177.8 TeV . The obtained spectrum is fully compatible with previous measurements of the atmospheric neutrino flux and recent IceCube measurements of a flux of high-energy astrophysical neutrinos.
Collapse
|
44
|
Gupta A, Ayub M, Miller C, Rothwell D, Wallace A, Jordan A, Cook N, Thistlethwaite F, Carter L, O’Brien C, Aruketty S, Dean E, Hudson A, Frese K, Dransfield J, Hughes A, Marais R, Dive C, Brady G, Krebs M. Development of the Manchester Cancer Research Centre Molecular Tumour Board for matching patients to clinical trials based on tumour and ctDNA genetic profiling. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx390] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Albert A, André M, Anghinolfi M, Anton G, Ardid M, Aubert JJ, Avgitas T, Baret B, Barrios-Martí J, Basa S, Bertin V, Biagi S, Bormuth R, Bourret S, Bouwhuis M, Bruijn R, Brunner J, Busto J, Capone A, Caramete L, Carr J, Celli S, Chiarusi T, Circella M, Coelho J, Coleiro A, Coniglione R, Costantini H, Coyle P, Creusot A, Deschamps A, De Bonis G, Distefano C, Di Palma I, Donzaud C, Dornic D, Drouhin D, Eberl T, El Bojaddaini I, Elsässer D, Enzenhöfer A, Felis I, Fusco L, Galatà S, Gay P, Giordano V, Glotin H, Grégoire T, Gracia Ruiz R, Graf K, Hallmann S, van Haren H, Heijboer A, Hello Y, Hernández-Rey J, Hößl J, Hofestädt J, Hugon C, Illuminati G, James C, de Jong M, Jongen M, Kadler M, Kalekin O, Katz U, Kießling D, Kouchner A, Kreter M, Kreykenbohm I, Kulikovskiy V, Lachaud C, Lahmann R, Lefèvre D, Leonora E, Lotze M, Loucatos S, Marcelin M, Margiotta A, Marinelli A, Martínez-Mora J, Mathieu A, Mele R, Melis K, Michael T, Migliozzi P, Moussa A, Nezri E, Păvălaş G, Pellegrino C, Perrina C, Piattelli P, Popa V, Pradier T, Quinn L, Racca C, Riccobene G, Sánchez-Losa A, Saldaña M, Salvadori I, Samtleben D, McIver J, McManus D, McRae T, McWilliams S, Meacher D, Meadors G, Meidam J, Melatos A, Mendell G, Mendoza-Gandara D, Sanguineti M, Mercer R, Merilh E, Merzougui M, Meshkov S, Messenger C, Messick C, Metzdorff R, Meyers P, Mezzani F, Miao H, Sapienza P, Michel C, Middleton H, Mikhailov E, Milano L, Miller A, Miller A, Miller B, Miller J, Millhouse M, Minenkov Y, Schüssler F, Ming J, Mirshekari S, Mishra C, Mitra S, Mitrofanov V, Mitselmakher G, Mittleman R, Moggi A, Mohan M, Mohapatra S, Sieger C, Montani M, Moore B, Moore C, Moraru D, Moreno G, Morriss S, Mours B, Mow-Lowry C, Mueller G, Muir A, Spurio M, Mukherjee A, Mukherjee D, Mukherjee S, Mukund N, Mullavey A, Munch J, Muniz E, Murray P, Mytidis A, Napier K, Stolarczyk T, Nardecchia I, Naticchioni L, Nelemans G, Nelson T, Neri M, Nery M, Neunzert A, Newport J, Newton G, Nguyen T, Taiuti M, Nielsen A, Nissanke S, Nitz A, Noack A, Nocera F, Nolting D, Normandin M, Nuttall L, Oberling J, Ochsner E, Tayalati Y, Oelker E, Ogin G, Oh J, Oh S, Ohme F, Oliver M, Oppermann P, Oram RJ, O’Reilly B, O’Shaughnessy R, Trovato A, Ottaway D, Overmier H, Owen B, Pace A, Page J, Pai A, Pai S, Palamos J, Palashov O, Palomba C, Turpin D, Pal-Singh A, Pan H, Pankow C, Pannarale F, Pant B, Paoletti F, Paoli A, Papa M, Paris H, Parker W, Tönnis C, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patricelli B, Pearlstone B, Pedraza M, Pedurand R, Pekowsky L, Pele A, Vallage B, Penn S, Perez C, Perreca A, Perri L, Pfeiffer H, Phelps M, Piccinni O, Pichot M, Piergiovanni F, Pierro V, Vallée C, Pillant G, Pinard L, Pinto I, Pitkin M, Poe M, Poggiani R, Popolizio P, Post A, Powell J, Prasad J, Van Elewyck V, Pratt J, Predoi V, Prestegard T, Prijatelj M, Principe M, Privitera S, Prodi G, Prokhorov L, Puncken O, Punturo M, Versari F, Puppo P, Pürrer M, Qi H, Qin J, Qiu S, Quetschke V, Quintero E, Quitzow-James R, Raab F, Rabeling D, Vivolo D, Radkins H, Raffai P, Raja S, Rajan C, Rakhmanov M, Rapagnani P, Raymond V, Razzano M, Re V, Read J, Vizzoca A, Regimbau T, Rei L, Reid S, Reitze D, Rew H, Reyes S, Rhoades E, Ricci F, Riles K, Rizzo M, Wilms J, Robertson N, Robie R, Robinet F, Rocchi A, Rolland L, Rollins J, Roma V, Romano R, Romie J, Rosińska D, Zornoza J, Rowan S, Rüdiger A, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadeghian L, Sakellariadou M, Salconi L, Saleem M, Zúñiga J, Salemi F, Samajdar A, Sammut L, Sampson L, Sanchez E, Sandberg V, Sanders J, Sassolas B, Sathyaprakash B, Saulson P, Aartsen M, Sauter O, Savage R, Sawadsky A, Schale P, Scheuer J, Schmidt E, Schmidt J, Schmidt P, Schnabel R, Schofield R, Ackermann M, Schönbeck A, Schreiber E, Schuette D, Schutz B, Schwalbe S, Scott J, Scott S, Sellers D, Sengupta A, Sentenac D, Adams J, Sequino V, Sergeev A, Setyawati Y, Shaddock D, Shaffer T, Shahriar M, Shapiro B, Shawhan P, Sheperd A, Shoemaker D, Aguilar J, Shoemaker D, Siellez K, Siemens X, Sieniawska M, Sigg D, Silva A, Singer A, Singer L, Singh A, Singh R, Ahlers M, Singhal A, Sintes A, Slagmolen B, Smith B, Smith J, Smith R, Son E, Sorazu B, Sorrentino F, Souradeep T, Ahrens M, Spencer A, Srivastava A, Staley A, Steinke M, Steinlechner J, Steinlechner S, Steinmeyer D, Stephens B, Stevenson S, Stone R, Al Samarai I, Strain K, Straniero N, Stratta G, Strigin S, Sturani R, Stuver A, Summerscales T, Sun L, Sunil S, Sutton P, Altmann D, Swinkels B, Szczepańczyk M, Tacca M, Talukder D, Tanner D, Tápai M, Taracchini A, Taylor R, Theeg T, Thomas E, Andeen K, Thomas M, Thomas P, Thorne K, Thrane E, Tippens T, Tiwari S, Tiwari V, Tokmakov K, Toland K, Tomlinson C, Anderson T, Tonelli M, Tornasi Z, Torrie C, Töyrä D, Travasso F, Traylor G, Trifirò D, Trinastic J, Tringali M, Trozzo L, Ansseau I, Tse M, Tso R, Turconi M, Tuyenbayev D, Ugolini D, Unnikrishnan C, Urban A, Usman S, Vahlbruch H, Vajente G, Anton G, Valdes G, van Bakel N, van Beuzekom M, van den Brand J, Van Den Broeck C, Vander-Hyde D, van der Schaaf L, van Heijningen J, van Veggel A, Vardaro M, Archinger M, Varma V, Vass S, Vasúth M, Vecchio A, Vedovato G, Veitch J, Veitch P, Venkateswara K, Venugopalan G, Verkindt D, Argüelles C, Vetrano F, Viceré A, Viets A, Vinciguerra S, Vine D, Vinet JY, Vitale S, Vo T, Vocca H, Vorvick C, Auffenberg J, Voss D, Vousden W, Vyatchanin S, Wade A, Wade L, Wade M, Walker M, Wallace L, Walsh S, Wang G, Axani S, Wang H, Wang M, Wang Y, Ward R, Warner J, Was M, Watchi J, Weaver B, Wei LW, Weinert M, Bagherpour H, Weinstein A, Weiss R, Wen L, Weßels P, Westphal T, Wette K, Whelan J, Whiting B, Whittle C, Williams D, Bai X, Williams R, Williamson A, Willis J, Willke B, Wimmer M, Winkler W, Wipf C, Wittel H, Woan G, Woehler J, Barwick S, Worden J, Wright J, Wu D, Wu G, Yam W, Yamamoto H, Yancey C, Yap M, Yu H, Yu H, Baum V, Yvert M, Zadrożny A, Zangrando L, Zanolin M, Zendri JP, Zevin M, Zhang L, Zhang M, Zhang T, Zhang Y, Bay R, Zhao C, Zhou M, Zhou Z, Zhu S, Zhu X, Zucker M, Zweizig J, Beatty J, Becker Tjus J, Becker KH, BenZvi S, Berley D, Bernardini E, Besson D, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Bradascio F, Braun J, Brayeur L, Bretz HP, Bron S, Burgman A, Carver T, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin G, Conrad J, Cowen D, Cross R, Day M, de André J, De Clercq C, del Pino Rosendo E, Dembinski H, De Ridder S, Desiati P, de Vries K, de Wasseige G, de With M, DeYoung T, Díaz-Vélez J, di Lorenzo V, Dujmovic H, Dumm J, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Euler S, Evenson P, Fahey S, Fazely A, Feintzeig J, Felde J, Filimonov K, Finley C, Flis S, Fösig CC, Franckowiak A, Friedman E, Fuchs T, Gaisser T, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Gladstone L, Glauch T, Glüsenkamp T, Goldschmidt A, Gonzalez J, Grant D, Griffith Z, Haack C, Hallgren A, Halzen F, Hansen E, Hansmann T, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill G, Hoffman K, Hoffmann R, Hoshina K, Huang F, Huber M, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze G, Jeong M, Jero K, Jones B, Kang W, Kappes A, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley J, Kheirandish A, Kim J, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein S, Kohnen G, Koirala R, Kolanoski H, Konietz R, Köpke L, Kopper C, Kopper S, Koskinen D, Kowalski M, Krings K, Kroll M, Krückl G, Krüger C, Kunnen J, Kunwar S, Kurahashi N, Kuwabara T, Kyriacou A, Labare M, Lanfranchi J, Larson M, Lauber F, Lennarz D, Lesiak-Bzdak M, Leuermann M, Lu L, Lünemann J, Madsen J, Maggi G, Mahn K, Mancina S, Maruyama R, Mase K, Maunu R, McNally F, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momenté G, Montaruli T, Moulai M, Nahnhauer R, Naumann U, Neer G, Niederhausen H, Nowicki S, Nygren D, Obertacke Pollmann A, Olivas A, O’Murchadha A, Palczewski T, Pandya H, Pankova D, Peiffer P, Penek Ö, Pepper J, Pérez de los Heros C, Pieloth D, Pinat E, Price P, Przybylski G, Quinnan M, Raab C, Rädel L, Rameez M, Rawlins K, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Sabbatini L, Sanchez Herrera S, Sandrock A, Sandroos J, Sarkar S, Satalecka K, Schlunder P, Schmidt T, Schoenen S, Schöneberg S, Schumacher L, Seckel D, Seunarine S, Soldin D, Song M, Spiczak G, Spiering C, Stachurska J, Stanev T, Stasik A, Stettner J, Steuer A, Stezelberger T, Stokstad R, Stößl A, Ström R, Strotjohann N, Sullivan G, Sutherland M, Taavola H, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale P, Tobin M, Toscano S, Tosi D, Tselengidou M, Tung C, Turcati A, Unger E, Usner M, Vandenbroucke J, van Eijndhoven N, Vanheule S, van Rossem M, van Santen J, Vehring M, Voge M, Vogel E, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Waza A, Weaver C, Weiss M, Wendt C, Westerhoff S, Whelan B, Wickmann S, Wiebe K, Wiebusch C, Wille L, Williams D, Wills L, Wolf M, Wood T, Woolsey E, Woschnagg K, Xu D, Xu X, Xu Y, Yanez J, Yodh G, Yoshida S, Zoll M, Abbott B, Abbott R, Abbott T, Abernathy M, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari R, Adya V, Affeldt C, Agathos M, Agatsuma K, Aggarwal N, Aguiar O, Aiello L, Ain A, Ajith P, Allen B, Allocca A, Altin P, Ananyeva A, Anderson S, Anderson W, Appert S, Arai K, Araya M, Areeda J, Arnaud N, Arun K, Ascenzi S, Ashton G, Ast M, Aston S, Astone P, Aufmuth P, Aulbert C, Avila-Alvarez A, Babak S, Bacon P, Bader M, Baker P, Baldaccini F, Ballardin G, Ballmer S, Barayoga J, Barclay S, Barish B, Barker D, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Bartos I, Bassiri R, Basti A, Batch J, Baune C, Bavigadda V, Bazzan M, Beer C, Bejger M, Belahcene I, Belgin M, Bell A, Berger B, Bergmann G, Berry C, Bersanetti D, Bertolini A, Betzwieser J, Bhagwat S, Bhandare R, Bilenko I, Billingsley G, Billman C, Birch J, Birney R, Birnholtz O, Biscans S, Bisht A, Bitossi M, Biwer C, Bizouard M, Blackburn J, Blackman J, Blair C, Blair D, Blair R, Bloemen S, Bock O, Boer M, Bogaert G, Bohe A, Bondu F, Bonnand R, Boom B, Bork R, Boschi V, Bose S, Bouffanais Y, Bozzi A, Bradaschia C, Brady P, Braginsky V, Branchesi M, Brau J, Briant T, Brillet A, Brinkmann M, Brisson V, Brockill P, Broida J, Brooks A, Brown D, Brown D, Brown N, Brunett S, Buchanan C, Buikema A, Bulik T, Bulten H, Buonanno A, Buskulic D, Buy C, Byer R, Cabero M, Cadonati L, Cagnoli G, Cahillane C, Calderón Bustillo J, Callister T, Calloni E, Camp J, Canepa M, Cannon K, Cao H, Cao J, Capano C, Capocasa E, Carbognani F, Caride S, Casanueva Diaz J, Casentini C, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda C, Cerboni Baiardi L, Cerretani G, Cesarini E, Chamberlin S, Chan M, Chao S, Charlton P, Chassande-Mottin E, Cheeseboro B, Chen H, Chen Y, Cheng HP, Chincarini A, Chiummo A, Chmiel T, Cho H, Cho M, Chow J, Christensen N, Chu Q, Chua A, Chua S, Chung S, Ciani G, Clara F, Clark J, Cleva F, Cocchieri C, Coccia E, Cohadon PF, Colla A, Collette C, Cominsky L, Constancio M, Conti L, Cooper S, Corbitt T, Cornish N, Corsi A, Cortese S, Costa C, Coughlin M, Coughlin S, Coulon JP, Countryman S, Couvares P, Covas P, Cowan E, Coward D, Cowart M, Coyne D, Coyne R, Creighton J, Creighton T, Cripe J, Crowder S, Cullen T, Cumming A, Cunningham L, Cuoco E, Dal Canton T, Danilishin S, D’Antonio S, Danzmann K, Dasgupta A, Da Silva Costa C, Dattilo V, Dave I, Davier M, Davies G, Davis D, Daw E, Day B, Day R, De S, DeBra D, Debreczeni G, Degallaix J, De Laurentis M, Deléglise S, Del Pozzo W, Denker T, Dent T, Dergachev V, De Rosa R, DeRosa R, DeSalvo R, Devine R, Dhurandhar S, Díaz M, Di Fiore L, Di Giovanni M, Di Girolamo T, Di Lieto A, Di Pace S, Di Palma I, Di Virgilio A, Doctor Z, Dolique V, Donovan F, Dooley K, Doravari S, Dorrington I, Douglas R, Dovale Álvarez M, Downes T, Drago M, Drever R, Driggers J, Du Z, Ducrot M, Dwyer S, Edo T, Edwards M, Effler A, Eggenstein HB, Ehrens P, Eichholz J, Eikenberry S, Eisenstein R, Essick R, Etienne Z, Etzel T, Evans M, Evans T, Everett R, Factourovich M, Fafone V, Fair H, Fairhurst S, Fan X, Farinon S, Farr B, Farr W, Fauchon-Jones E, Favata M, Fays M, Fehrmann H, Fejer M, Fernández Galiana A, Ferrante I, Ferreira E, Ferrini F, Fidecaro F, Fiori I, Fiorucci D, Fisher R, Flaminio R, Fletcher M, Fong H, Forsyth S, Fournier JD, Frasca S, Frasconi F, Frei Z, Freise A, Frey R, Frey V, Fries E, Fritschel P, Frolov V, Fulda P, Fyffe M, Gabbard H, Gadre B, Gaebel S, Gair J, Gammaitoni L, Gaonkar S, Garufi F, Gaur G, Gayathri V, Gehrels N, Gemme G, Genin E, Gennai A, George J, Gergely L, Germain V, Ghonge S, Ghosh A, Ghosh A, Ghosh S, Giaime J, Giardina K, Giazotto A, Gill K, Glaefke A, Goetz E, Goetz R, Gondan L, González G, Gonzalez Castro J, Gopakumar A, Gorodetsky M, Gossan S, Gosselin M, Gouaty R, Grado A, Graef C, Granata M, Grant A, Gras S, Gray C, Greco G, Green A, Groot P, Grote H, Grunewald S, Guidi G, Guo X, Gupta A, Gupta M, Gushwa K, Gustafson E, Gustafson R, Hacker J, Hall B, Hall E, Hammond G, Haney M, Hanke M, Hanks J, Hanna C, Hannam M, Hanson J, Hardwick T, Harms J, Harry G, Harry I, Hart M, Hartman M, Haster CJ, Haughian K, Healy J, Heidmann A, Heintze M, Heitmann H, Hello P, Hemming G, Hendry M, Heng I, Hennig J, Henry J, Heptonstall A, Heurs M, Hild S, Hoak D, Hofman D, Holt K, Holz D, Hopkins P, Hough J, Houston E, Howell E, Hu Y, Huerta E, Huet D, Hughey B, Husa S, Huttner S, Huynh-Dinh T, Indik N, Ingram D, Inta R, Isa H, Isac JM, Isi M, Isogai T, Iyer B, Izumi K, Jacqmin T, Jani K, Jaranowski P, Jawahar S, Jiménez-Forteza F, Johnson W, Jones D, Jones R, Jonker R, Ju L, Junker J, Kalaghatgi C, Kalogera V, Kandhasamy S, Kang G, Kanner J, Karki S, Karvinen K, Kasprzack M, Katsavounidis E, Katzman W, Kaufer S, Kaur T, Kawabe K, Kéfélian F, Keitel D, Kelley D, Kennedy R, Key J, Khalili F, Khan I, Khan S, Khan Z, Khazanov E, Kijbunchoo N, Kim C, Kim J, Kim W, Kim W, Kim YM, Kimbrell S, King E, King P, Kirchhoff R, Kissel J, Klein B, Kleybolte L, Klimenko S, Koch P, Koehlenbeck S, Koley S, Kondrashov V, Kontos A, Korobko M, Korth W, Kowalska I, Kozak D, Krämer C, Kringel V, Królak A, Kuehn G, Kumar P, Kumar R, Kuo L, Kutynia A, Lackey B, Landry M, Lang R, Lange J, Lantz B, Lanza R, Lartaux-Vollard A, Lasky P, Laxen M, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lebigot E, Lee C, Lee H, Lee H, Lee K, Lehmann J, Lenon A, Leonardi M, Leong J, Leroy N, Letendre N, Levin Y, Li T, Libson A, Littenberg T, Liu J, Lockerbie N, Lombardi A, London L, Lord J, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lough J, Lovelace G, Lück H, Lundgren A, Lynch R, Ma Y, Macfoy S, Machenschalk B, MacInnis M, Macleod D, Magaña-Sandoval F, Majorana E, Maksimovic I, Malvezzi V, Man N, Mandic V, Mangano V, Mansell G, Manske M, Mantovani M, Marchesoni F, Marion F, Márka S, Márka Z, Markosyan A, Maros E, Martelli F, Martellini L, Martin I, Martynov D, Mason K, Masserot A, Massinger T, Masso-Reid M, Mastrogiovanni S, Matichard F, Matone L, Mavalvala N, Mazumder N, McCarthy R, McClelland D, McCormick S, McGrath C, McGuire S, McIntyre G. Search for high-energy neutrinos from gravitational wave event GW151226 and candidate LVT151012 with ANTARES and IceCube. Int J Clin Exp Med 2017. [DOI: 10.1103/physrevd.96.022005] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
46
|
Raffel J, Wallace A, Gveric D, Reynolds R, Friede T, Nicholas R. Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29. PLoS Med 2017; 14:e1002346. [PMID: 28692670 PMCID: PMC5503162 DOI: 10.1371/journal.pmed.1002346] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2017] [Accepted: 06/07/2017] [Indexed: 01/05/2023] Open
Abstract
BACKGROUND There is increasing emphasis on using patient-reported outcomes (PROs) to complement traditional clinical outcomes in medical research, including in multiple sclerosis (MS). Research, particularly in oncology and heart failure, has shown that PROs can be prognostic of hard clinical endpoints such as survival time (time from study entry until death). However, unlike in oncology or cardiology, it is unknown whether PROs are associated with survival time in neurological diseases. The Multiple Sclerosis Impact Scale-29 (MSIS-29) is a PRO sensitive to short-term change in MS, with questions covering both physical and psychological quality of life. This study aimed to investigate whether MSIS-29 scores can be prognostic for survival time in MS, using a large observational cohort of people with MS. METHODS AND FINDINGS From 15 July 2004 onwards, MSIS-29 questionnaires were completed by people with MS registered with the MS Society Tissue Bank (n = 2,126, repeated 1 year later with n = 872 of the original respondents). By 2014, 264 participants (12.4%) had died. Higher baseline MSIS-29 physical (MSIS-29-PHYS) score was associated with reduced survival time (subgroup with highest scores versus subgroup with lowest scores: hazard ratio [HR] 5.7, 95% CI 3.1-10.5, p < 0.001). Higher baseline MSIS-29 psychological score was also associated with reduced survival time (subgroup with highest scores versus subgroup with lowest scores: HR 2.8, 95% CI 1.8-4.4, p < 0.001). In those with high baseline MSIS-29 scores, mortality risk was even greater if the MSIS-29 score worsened over 1 year (HR 2.3, 95% CI 1.2-4.4, p = 0.02). MSIS-29-PHYS scores were associated with survival time independent of age, sex, and patient-reported Expanded Disability Status Scale score in a Cox regression analysis (per 1-SD increase in MSIS-29-PHYS score: HR 1.8, 95% CI 1.1-2.9, p = 0.03). A limitation of the study is that this cohort had high baseline age and disability levels; the prognostic value of MSIS-29 for survival time at earlier disease stages requires further investigation. CONCLUSIONS This study reports that PROs can be prognostic for hard clinical outcomes in neurological disease, and supports PROs as a meaningful clinical outcome for use in research and clinical settings.
Collapse
|
47
|
Wallace A, Eady S, Drummond L, Hedderley D, Ansell J, Gearry R. A Pilot Randomized Cross-Over Trial to Examine the Effect of Kiwifruit on Satiety and Measures of Gastric Comfort in Healthy Adult Males. Nutrients 2017. [PMID: 28640214 PMCID: PMC5537759 DOI: 10.3390/nu9070639] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
‘Hayward’ kiwifruit anecdotally are associated with improved gastrointestinal comfort following the consumption of high protein meals, possibly because of the presence of a protease enzyme, actinidin. The study aimed to use SmartPill™ technology to investigate the acute effect of kiwifruit with actinidin (Actinidia chinensis var. deliciosa ‘Hayward’) and kiwifruit without actinidin (A. chinensis var. chinensis ‘Hort16A’) on digestion of a large protein meal. Ten healthy male subjects were recruited. The participants attended the clinic three times, having fasted overnight. They consumed a test meal consisting of 400 g lean steak and two ‘Hort16A’ or two ‘Hayward kiwifruit’. Subjects completed visual analogue scales (VAS) by rating feelings of hunger, satisfaction, fullness, and comfort and swallowed a SmartPill™ before completing further VAS scales. After 5 h, participants consumed an ad libitum lunch to assess satiety. SmartPill™ transponders were worn for five days. There were no significant differences in gastric emptying time, small bowel, or colonic transit time between the two kiwifruit arms of the study measured by SmartPill™. Similarly, no significant differences were observed in VAS satiety measures or energy consumption at the ad libitum meal. However, the measurement of overall gastric comfort tended to be lower, and bloating was significantly reduced following the consumption of the steak meal with ‘Hayward’ kiwifruit (p < 0.028). Conclusions: The SmartPill™ is marketed as a diagnostic tool for patients presenting with gastrointestinal disorders and is usually used with a standard ‘SmartBar’. This small pilot study suggests that it is less likely to measure gastric emptying effectively following a high protein meal, as it may be delayed because of the meal’s physical consistency. However, green kiwifruit, containing actinidin, may reduce bloating and other measures of gastric discomfort in healthy males. Possible future studies could use repeated measures with more readily digested protein and larger numbers of participants.
Collapse
|
48
|
Thomas K, Brindle R, Chalmers J, Gamble B, Francis N, Hardy D, Hooper J, Keeley V, Levell N, McPhee M, Metcalf L, Santer M, Tarpey M, Smart P, Wallace A, Wilkes S. Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership. Br J Dermatol 2017; 177:541-543. [DOI: 10.1111/bjd.15634] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Shah M, Jensen R, Yau C, Straehley I, Berry DA, DeMichele A, Buxton MB, Hylton NM, Perlmutter J, Symmans WF, Tripathy D, Yee D, Wallace A, Kaplan HG, Clark A, Chien AJ, Esserman LJ, Melisko ME. Abstract P5-11-18: Trajectory of patient (Pt) reported physical function (PF) during and after neoadjuvant chemotherapy in the I-SPY 2 trial. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-11-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Patients (pts) receiving chemotherapy for breast cancer experience toxicities impacting short and long-term quality of life (QOL). Within I-SPY 2, a trial adaptively randomizing stage II/III breast cancer pts to neoadjuvant chemotherapy +/- an investigational agent, we are collecting pt reported outcome (PRO) data to understand the impact of investigational agents on QOL. This PRO sub-study provides a unique opportunity to study QOL longitudinally and explore how pt and tumor characteristics, exposure to investigational therapies, and surgical outcome impact QOL.
Methods
Pts enrolled in this trial receive paclitaxel (T) +/- an investigational agent for 12 weeks followed by 4 cycles of doxorubicin and cyclophosphamide (AC). Surveys include the EORTC QLQ-C30 and BR-23, and PROMIS measures for QOL metrics including but not limited to physical function (PF), anxiety, and depression. Surveys are administered pre-chemotherapy to 2 years post-surgery. PF data from the EORTC and PROMIS instruments was analyzed for 238 pts at 5 sites (UCSF, UCSD, U of Pennsylvania, U of Minnesota, and Swedish Cancer Center). 48 pts completed baseline, inter-regimen (between T and AC), pre-operative and post-surgery surveys. Of the 48 pts 32 completed a 6-month follow up (FUP) and 31 completed a 1-year FUP survey. A linear mixed effect model, adjusting for HER2 status and treatment type was used to evaluate changes in PF over time. Sample size is small and statistics are descriptive rather than inferential.
Results
Median age of pts in this analysis was 50 (range 27-72).
Table 1 shows PROMIS & EORTC PF scores in this cohort.Time Point PROMISEORTC nMeanSEMeanSEPre-TreatmentAll4852.51.092.02.0 HER2+1553.51.594.12.2 HER2-3352.11.391.12.8Inter-RegimenAll4845.51.282.22.7 HER2+1548.62.384.44.2 HER2-3344.11.381.23.4Pre-SurgeryAll4843.91.179.42.3 HER2+1545.12.275.34.1 HER2-3343.41.381.32.86-Month FUPAll3248.11.487.41.9 HER2+1247.52.285.03.3 HER2-2048.41.888.92.41 Year FUPAll3148.91.488.43.1 HER2+949.12.988.95.4 HER2-2248.81.788.33.8
At baseline, mean PROMIS PF scores were higher than the US average (mean = 50) but declined as expected throughout treatment. HER2+ patients experienced a similar degree of recovery as HER2- pts post-surgery despite adjuvant treatment with Herceptin. Analysis of post-operative PROMIS PF indicated an average score within the U.S. general population (mean =50) but did not return to higher functioning seen at baseline levels (mean 52.5, p-value < 0.05). Analysis of the EORTC PF sub-scale demonstrated a similar trend; however, the baseline and post-operative difference was not significant (p-value=0.15 for both FUP). Finding supports PROMIS PF ability to measure high functioning cancer patients.
Conclusions: Among a subset of pts who completed all surveys in the I-SPY 2 QOL substudy, PF did not return to baseline at 6-12 months post-operatively. Through transition to an electronic platform of data collection we hope to improve compliance with survey completion. We continue to analyze other QOL measures and plan to correlate QOL data with treatment arm, adverse events, comorbidities, and response to neoadjuvant treatment.
Citation Format: Shah M, Jensen R, Yau C, Straehley I, Berry DA, DeMichele A, Buxton MB, Hylton NM, Perlmutter J, Symmans WF, Tripathy D, Yee D, Wallace A, Kaplan HG, Clark A, Chien AJ, I-SPY 2 Investigators, Esserman LJ, Melisko ME. Trajectory of patient (Pt) reported physical function (PF) during and after neoadjuvant chemotherapy in the I-SPY 2 trial [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-11-18.
Collapse
|
50
|
Wallace A, Madaelil T, Austin M, Wiesner E, Jennings J. Percutaneous image-guided ablation of musculoskeletal non–small cell lung cancer metastases: pain palliation, local tumor control, and remission of oligometastatic disease. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|